Early-stage beta
· Errors & gaps may exist · Expanding: US · Nordics · EU
← All companies
/
Top lists
/
Dexcom
Dexcom
2017–2025 · Healthcare
2026-08-11
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
719
1 032
1 476
1 927
2 449
2 910
3 622
4 033
4 662
Operating profit (EBIT)
−42
−186
142
300
266
391
598
600
912
Net income attributable to shareholders
−50
−127
101
494
155
341
542
576
836
EBIT margin
−5,9%
−18,1%
9,6%
15,5%
10,9%
13,4%
16,5%
14,9%
19,6%
Gross margin
—
64,4%
63,1%
66,4%
68,6%
64,7%
63,2%
60,5%
60,1%
Operating cash flow
92
123
315
476
443
670
749
990
1 441
Free cash flow
26
56
135
277
53
305
512
631
1 077
Cash
442
1 137
446
818
1 053
642
566
606
918
Interest-bearing debt
328
1 010
1 075
1 730
1 763
2 034
2 498
2 506
1 301
−2 000
0
2 000
4 000
6 000
−20,0%
−10,0%
0,0%
10,0%
20,0%
30,0%
2017
2018
2019
2020
2021
2022
2023
2024
2025
719
1 032
1 476
1 927
2 449
2 910
3 622
4 033
4 662
−42
−186
142
300
266
391
598
600
912